|
2012-09-06 |
2012-09-05 |
B
Purchase
|
SPECTRUM PHARMACEUTICALS INC
Large shareholder
|
130,854,840
+100.0%
1.82
USD 238,155,809
|
130,854,840
+100.0%
|
1.82
|
USD 238,155,809
|
|
|
2012-03-01 |
2012-03-01 |
PS
Planned sale
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Officer
|
3,025
-2.0%
1.50
USD 4,522
|
3,025
-2.0%
|
1.50
|
USD 4,522
|
|
|
2012-03-01 |
2012-02-29 |
PS
Planned sale
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Officer
|
3,031
-2.0%
1.53
USD 4,623
|
3,031
-2.0%
|
1.53
|
USD 4,623
|
|
|
2012-02-27 |
2012-02-24 |
PS
Planned sale
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Officer
|
1,469
-1.3%
1.55
USD 2,277
|
1,469
-1.3%
|
1.55
|
USD 2,277
|
|
|
2011-02-25 |
2011-02-24 |
PS
Planned sale
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Officer
|
1,469
-1.5%
3.20
USD 4,701
|
1,469
-1.5%
|
3.20
|
USD 4,701
|
|
|
2010-05-12 |
2010-05-10 |
PS
Planned sale
|
Clark David C
VP, Finance
Officer
|
3,085
-15.3%
7.03
USD 21,684
|
3,085
-15.3%
|
7.03
|
USD 21,684
|
|
|
2010-04-14 |
2010-04-12 |
PS
Planned sale
|
Graboyes Marc H
SVP, General Counsel
Officer
|
75,000
-56.4%
8.58
USD 643,530
|
75,000
-56.4%
|
8.58
|
USD 643,530
|
|
|
2010-03-12 |
2010-03-10 |
PS
Planned sale
|
Clark David C
VP, Finance
Officer
|
20,000
-50.8%
7.78
USD 155,612
|
20,000
-50.8%
|
7.78
|
USD 155,612
|
|
|
2010-03-08 |
2010-03-05 |
PS
Planned sale
|
Clark David C
VP, Finance
Officer
|
10,000
-34.1%
7.02
USD 70,196
|
10,000
-34.1%
|
7.02
|
USD 70,196
|
|
|
2010-03-08 |
2010-03-04 |
PS
Planned sale
|
Clark David C
VP, Finance
Officer
|
11,640
-37.6%
6.98
USD 81,301
|
11,640
-37.6%
|
6.98
|
USD 81,301
|
|
|
2010-03-03 |
2010-03-01 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
37,500
-26.6%
8.13
USD 304,875
|
37,500
-26.6%
|
8.13
|
USD 304,875
|
|
|
2010-03-03 |
2010-03-01 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
40,000
-22.1%
8.13
USD 325,204
|
40,000
-22.1%
|
8.13
|
USD 325,204
|
|
|
2010-02-24 |
2010-02-24 |
PS
Planned sale
|
BERNS PAUL L
Chief Executive Officer
Officer
|
7,362
-3.2%
7.57
USD 55,766
|
7,362
-3.2%
|
7.57
|
USD 55,766
|
|
|
2010-02-24 |
2010-02-24 |
PS
Planned sale
|
Graboyes Marc H
SVP, General Counsel
Officer
|
2,349
-3.9%
7.44
USD 17,477
|
2,349
-3.9%
|
7.44
|
USD 17,477
|
|
|
2010-02-24 |
2010-02-23 |
PS
Planned sale
|
BERNS PAUL L
Chief Executive Officer
Officer
|
4,304
-1.8%
7.51
USD 32,331
|
4,304
-1.8%
|
7.51
|
USD 32,331
|
|
|
2010-02-24 |
2010-02-23 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
5,968
-4.1%
7.44
USD 44,378
|
5,968
-4.1%
|
7.44
|
USD 44,378
|
|
|
2010-02-24 |
2010-02-23 |
PS
Planned sale
|
Graboyes Marc H
SVP, General Counsel
Officer
|
1,416
-2.3%
7.51
USD 10,634
|
1,416
-2.3%
|
7.51
|
USD 10,634
|
|
|
2010-02-24 |
2010-02-23 |
PS
Planned sale
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Officer
|
1,468
-6.0%
7.51
USD 11,025
|
1,468
-6.0%
|
7.51
|
USD 11,025
|
|
|
2010-01-11 |
2010-01-11 |
PS
Planned sale
|
HOFFMAN STEPHEN J
Non-Executive Director
|
45,428
-8.7%
7.30
USD 331,738
|
45,428
-8.7%
|
7.30
|
USD 331,738
|
|
|
2010-01-11 |
2010-01-08 |
PS
Planned sale
|
HOFFMAN STEPHEN J
Non-Executive Director
|
45,429
-8.7%
7.11
USD 322,918
|
45,429
-8.7%
|
7.11
|
USD 322,918
|
|
|
2010-01-11 |
2010-01-07 |
PS
Planned sale
|
HOFFMAN STEPHEN J
Non-Executive Director
|
45,429
-8.7%
6.76
USD 307,114
|
45,429
-8.7%
|
6.76
|
USD 307,114
|
|
|
2010-01-06 |
2010-01-06 |
PS
Planned sale
|
HOFFMAN STEPHEN J
Non-Executive Director
|
45,429
-8.7%
6.78
USD 308,163
|
45,429
-8.7%
|
6.78
|
USD 308,163
|
|
|
2010-01-06 |
2010-01-05 |
PS
Planned sale
|
HOFFMAN STEPHEN J
Non-Executive Director
|
45,428
-8.7%
6.64
USD 301,497
|
45,428
-8.7%
|
6.64
|
USD 301,497
|
|
|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
HOFFMAN STEPHEN J
Non-Executive Director
|
25,428
-5.1%
6.54
USD 166,220
|
25,428
-5.1%
|
6.54
|
USD 166,220
|
|
|
2009-08-12 |
2009-08-10 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
85,400
-49.0%
8.13
USD 694,302
|
85,400
-49.0%
|
8.13
|
USD 694,302
|
|
|
2009-08-12 |
2009-08-10 |
PS
Planned sale
|
BERNS PAUL L
Chief Executive Officer
Officer
|
342,000
-59.6%
8.24
USD 2,819,311
|
342,000
-59.6%
|
8.24
|
USD 2,819,311
|
|
|
2009-08-07 |
2009-08-05 |
PS
Planned sale
|
BERNS PAUL L
Chief Executive Officer
Officer
|
8,000
-3.3%
8.14
USD 65,150
|
8,000
-3.3%
|
8.14
|
USD 65,150
|
|
|
2009-08-05 |
2009-08-05 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
14,600
-14.1%
8.13
USD 118,755
|
14,600
-14.1%
|
8.13
|
USD 118,755
|
|
|
2009-08-05 |
2009-08-03 |
PS
Planned sale
|
Graboyes Marc H
VP, General Counsel
Officer
|
50,000
-71.4%
8.00
USD 400,000
|
50,000
-71.4%
|
8.00
|
USD 400,000
|
|
|
2009-08-05 |
2009-08-03 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
50,000
-36.0%
7.79
USD 389,480
|
50,000
-36.0%
|
7.79
|
USD 389,480
|
|
|
2009-03-27 |
2009-03-26 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
39,500
-25.3%
7.37
USD 291,206
|
39,500
-25.3%
|
7.37
|
USD 291,206
|
|
|
2009-03-27 |
2009-03-25 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
6,900
-5.6%
7.13
USD 49,209
|
6,900
-5.6%
|
7.13
|
USD 49,209
|
|
|
2009-03-16 |
2009-03-16 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
3,600
-3.0%
7.13
USD 25,674
|
3,600
-3.0%
|
7.13
|
USD 25,674
|
|
|
2009-03-16 |
2009-03-13 |
PS
Planned sale
|
Clark David C
VP, Finance
Officer
|
5,027
-41.3%
7.00
USD 35,189
|
5,027
-41.3%
|
7.00
|
USD 35,189
|
|
|
2009-03-16 |
2009-03-13 |
PS
Planned sale
|
Graboyes Marc H
VP, General Counsel
Officer
|
5,864
-22.6%
7.00
USD 41,048
|
5,864
-22.6%
|
7.00
|
USD 41,048
|
|
|
2009-03-16 |
2009-03-12 |
PS
Planned sale
|
Clark David C
VP, Finance
Officer
|
64,973
-90.1%
7.02
USD 455,812
|
64,973
-90.1%
|
7.02
|
USD 455,812
|
|
|
2009-03-16 |
2009-03-12 |
PS
Planned sale
|
CARUSO JAMES V
Chief Commercial Officer
Officer
|
50,000
-30.1%
7.13
USD 356,500
|
50,000
-30.1%
|
7.13
|
USD 356,500
|
|
|
2009-03-16 |
2009-03-12 |
PS
Planned sale
|
Graboyes Marc H
VP, General Counsel
Officer
|
69,136
-77.5%
7.02
USD 485,010
|
69,136
-77.5%
|
7.02
|
USD 485,010
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
22
-0.0%
8.26
USD 182
|
22
-0.0%
|
8.26
|
USD 182
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
24,857
-11.5%
8.17
USD 203,176
|
24,857
-11.5%
|
8.17
|
USD 203,176
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
1
-0.0%
8.26
USD 8
|
1
-0.0%
|
8.26
|
USD 8
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
705
-11.5%
8.17
USD 5,763
|
705
-11.5%
|
8.17
|
USD 5,763
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
235
-0.0%
8.26
USD 1,940
|
235
-0.0%
|
8.26
|
USD 1,940
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
263,312
-11.5%
8.17
USD 2,152,260
|
263,312
-11.5%
|
8.17
|
USD 2,152,260
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
212
-11.5%
8.17
USD 1,733
|
212
-11.5%
|
8.17
|
USD 1,733
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
8
-0.0%
8.26
USD 66
|
8
-0.0%
|
8.26
|
USD 66
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
9,380
-11.5%
8.17
USD 76,670
|
9,380
-11.5%
|
8.17
|
USD 76,670
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
670
-0.0%
8.26
USD 5,532
|
670
-0.0%
|
8.26
|
USD 5,532
|
|
|
2009-02-06 |
2009-02-06 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
751,534
-11.5%
8.17
USD 6,142,889
|
751,534
-11.5%
|
8.17
|
USD 6,142,889
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
4,725
-2.1%
8.11
USD 38,299
|
4,725
-2.1%
|
8.11
|
USD 38,299
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
1,200
-0.5%
8.17
USD 9,806
|
1,200
-0.5%
|
8.17
|
USD 9,806
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
6,392
-2.8%
8.16
USD 52,180
|
6,392
-2.8%
|
8.16
|
USD 52,180
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
134
-2.1%
8.11
USD 1,086
|
134
-2.1%
|
8.11
|
USD 1,086
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
34
-0.5%
8.17
USD 278
|
34
-0.5%
|
8.17
|
USD 278
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
181
-2.8%
8.16
USD 1,478
|
181
-2.8%
|
8.16
|
USD 1,478
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
50,041
-2.1%
8.11
USD 405,617
|
50,041
-2.1%
|
8.11
|
USD 405,617
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
12,713
-0.5%
8.17
USD 103,882
|
12,713
-0.5%
|
8.17
|
USD 103,882
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
67,709
-2.8%
8.16
USD 552,729
|
67,709
-2.8%
|
8.16
|
USD 552,729
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
40
-2.1%
8.11
USD 324
|
40
-2.1%
|
8.11
|
USD 324
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
10
-0.5%
8.17
USD 82
|
10
-0.5%
|
8.17
|
USD 82
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
55
-2.8%
8.16
USD 449
|
55
-2.8%
|
8.16
|
USD 449
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
1,782
-2.1%
8.11
USD 14,444
|
1,782
-2.1%
|
8.11
|
USD 14,444
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
453
-0.5%
8.17
USD 3,702
|
453
-0.5%
|
8.17
|
USD 3,702
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
2,411
-2.8%
8.16
USD 19,682
|
2,411
-2.8%
|
8.16
|
USD 19,682
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
142,827
-2.1%
8.11
USD 1,157,713
|
142,827
-2.1%
|
8.11
|
USD 1,157,713
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
36,286
-0.5%
8.17
USD 296,504
|
36,286
-0.5%
|
8.17
|
USD 296,504
|
|
|
2009-02-06 |
2009-02-05 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
193,252
-2.8%
8.16
USD 1,577,574
|
193,252
-2.8%
|
8.16
|
USD 1,577,574
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
24,256
-9.6%
8.46
USD 205,191
|
24,256
-9.6%
|
8.46
|
USD 205,191
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
2,593
-1.0%
8.47
USD 21,961
|
2,593
-1.0%
|
8.47
|
USD 21,961
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
269
-0.1%
9.03
USD 2,430
|
269
-0.1%
|
9.03
|
USD 2,430
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
688
-9.6%
8.46
USD 5,820
|
688
-9.6%
|
8.46
|
USD 5,820
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
74
-1.0%
8.47
USD 627
|
74
-1.0%
|
8.47
|
USD 627
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
BAKER JULIAN
Large shareholder
|
8
-0.1%
9.03
USD 72
|
8
-0.1%
|
9.03
|
USD 72
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
256,936
-9.6%
8.46
USD 2,173,524
|
256,936
-9.6%
|
8.46
|
USD 2,173,524
|
|
|
2009-02-06 |
2009-02-04 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
27,485
-1.1%
8.47
USD 232,781
|
27,485
-1.1%
|
8.47
|
USD 232,781
|
|
